Diamonds and Dogs
Thermo Fisher Scientific (TMO) is heating up. The world's largest maker of scientific instruments is up a percent not far from all-time highs after agreeing to acquire privately held, Brammer Bio for $1.7 billion cash deal. Brammer Bio is a leader in viral vector manufacturing for gene and cell therapies. As one analyst put it, gene therapy is considered to be "the next frontier" in drug development, and buying Brammer Bio gives Thermo Fisher a "foothold in the space."
A downgrade in the chip space. Texas Instruments (TXN) is down 3% following comments at Bernstein saying they are increasingly concerned that the chip-industry upturn may not happen this year. Micron (MU) is down 3% after jumping just as much last week following earnings and optimistic comments about a chip recovery. Since the second half of the year is still months away, it is probably too soon to know.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.